HCBD-Pro Services
Client Subscribers
HIPN Daily Archive
No Password Required
HIPN Daily SignUp
free e-newsletter
No Password Required
Current Headlines
No Password Required
Events Calendar
No Password Required
HCBD-PRO Services
Search Companies
Search People
Search News|Events
Query News -
By Companies
By People
HR Announcements
Health Plan Industry
MailingList Rental
HCBD-EmailSend
Broadcast Email
HCBD Journalist Wire
News Distribution
Website | e-newsletter
Online Advertising
Trade Conf | Webinar
Event Promotion
Welcome <Guest>
Login
Charles Cote
Former Vice President - Strategic Communications
Pharmaceutical Care Management Association (PCMA)
Office Location:
Washington, DC USA
Company Information:
601 Pennsylvania Ave, NW
S Bldg Ste 740
Washington,
DC
20004
USA
202-207-3610
HCBD Company Profile:
Pharmaceutical Care Management Association (PCMA)
Company Website:
http://www.pcmanet.org
Contact the Company
In The News
PCMA President and CEO Mark Merritt to Depart At Year-End
PCMA on New PwC Report: PBMs Driving Competition to Reduce Drug Costs
PCMA Launches New Campaign: 'That's What PBMs Do'
PBMs Provide Policy Solutions to Increase Competition, Reduce Rx Costs
View all remaining In The Stories headlines
PCMA: Lower Cost, Preferred Pharmacies Popular with Seniors in Medicare Part D
PCMA: New OIG Report Cites Drug Manufacturer "Copay Coupon" Use in Medicare Part D
PCMA: New Milliman Study - Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015
PCMA Statement on New CMS Medicare Part D Proposed Rule
PCMA: Eight Ways to Reduce Federal Health Spending and Improve Prescription Drug Benefits in Medicare and Medicaid
PCMA Statement on CMS Analysis of Preferred Pharmacy Networks in Medicare Part D
PCMA: Medicare Trustees Report Shows PBMs are Delivering Savings in Part D
PCMA: Report - Upgrading Medicaid Drug Benefits Could Save Pennsylvania $896 Million
PCMA Report: Upgrading Medicaid Drug Benefits Could Save Federal, State Governments $74.4 Billion
PCMA Recruits Wendy Krasner as New Vice President of Regulatory Affairs
PCMA Statement on Essential Health Benefits Final Rule
PCMA: 88 U.S. Representatives Urge USPS to Preserve Six Day Delivery of Mail-Service Pharmacy
PCMA Statement on Essential Health Benefits Proposed Rule
PCMA: New Study - Reforming Medicaid Pharmacy Saves New York $425 Million in 2012
PCMA Outlines $100 Billion in Prescription Drug Savings to Help Avoid Sequestration Budget Cuts
PCMA: Part D Plans and PBMs Continue to Deliver Savings in Medicare
PCMA: New Study Finds Generic Medications Saved $1 Trillion Over the Last Decade
New PCMA Ad Campaign: 'It's the Drugstore Lobby vs. Employers'
PCMA: Mail-Service Pharmacies Will Save Consumers and Payers Nearly $47 Billion Over the Next Decade
PCMA: Medicare Part D Preferred Pharmacy Networks Reducing Costs, Popular with Seniors
PCMA Launches New Missouri Ad Campaign: 'That's What PBMs Do'
PCMA: Medicare Part D Preferred Pharmacy Networks Reducing Costs, Popular with Seniors
PCMA Launches New Oregon Ad Campaign: 'That's What PBMs Do'
PCMA: Texas to Modernize Medicaid Rx Benefits, Curb Pharmacy Overpayments
PCMA: New Consumer Survey Finds Overwhelming Satisfaction with Pharmacy Benefits
New PCMA Multimedia Campaign: PBMs Provide Consumers and Payers Increased Savings, Safety, and Convenience
PCMA: Some Essential Benefits Rules Could Worry Small Businesses
PCMA: New Study Finds Mail-Service Pharmacies Improve Adherence to Diabetes Medications in Medicare Part D
PCMA: Part D Plans and PBMs Continue to Deliver Savings in Medicare
PCMA Statement on New JAMA Study: Medicare Drug Benefit Reduces Other Medical Costs
PCMA Comments on New Study that Finds Mail-Service Pharmacies Improve Outcomes for Patients Using Cholesterol Medications
PCMA - Setting the Record Straight: Mail-Service Pharmacies Driving Generic Utilization
Generic Drug Industry Honors PCMA President & CEO Mark Merritt with Prestigious ‘Outstanding Contribution’ Award
PCMA: HHS Encourages State Medicaid Programs to Use more Generic Drugs
PCMA: Ohio's Medicaid Program Could Save $135 Million
The Lewin Group: Mississippi Medicaid Could Save $65 Million Over Ten Years by Managing Medicaid Pharmacy More Like Medicare and Commercial Sector Programs
PCMA: Health Affairs Study Finds Substantial Medical Savings When Patients with Vascular Disease Stick to their Medications
PCMA Poll: Voters Want to Reduce Wasteful Spending in Medicaid Pharmacy
PCMA: New OIG Report - PBM Negotiations with Pharmacies Lower Drug Prices for Medicare Part D Beneficiaries
PCMA: New Law Ending Immediate Payment for Unverified Claims in Medicare a Step in the Right Direction
PCMA Applauds New CMS Rules Designed to Crack Down on Fraud in Medicare, Medicaid
PCMA: New J.D. Power Study - Mail-Service Pharmacies are Popular with Consumers
PCMA: New CBO Research Finds Use of Generic Drugs in Medicare Part D Saved Beneficiaries and Program $33 Billion in 2007
PCMA Welcomes WellPoint as Newest Member
PCMA: New AARP Study on Brand-Name Drug Price Increases Underscores Need for Greater Use of PBM Cost-Saving Tools
PCMA Statement: CMS: Part D Costs $261 Billion Lower than Expected
PCMA: CMS Turns ‘Transparency’ Spotlight on Drugstores
PCMA: Legislation to Increase Funding to Combat Fraud ‘Critical’ to Enhancing Program Integrity
PCMA Statement on Final EHR ‘Meaningful Use’ Rules
PCMA: Top Federal Appeals Court Strikes Down D.C.'s Controversial PBM Fiduciary Law
PCMA: Disrupting Mail Delivery Schedule Could Negatively Impact Consumers Relying on Home Delivery of Prescription Drugs
PCMA: Drug Company Price Hikes Highlight Need for More Competition in Medicare Part D
PCMA: New Legislation Would Increase Prescription Drug Costs, Limit Access
PCMA: Proposed Overhaul of FEHBP Pharmacy BenefitWould Undermine Cost-Saving Tools, Reduce Choices for 8 Million Americans
PCMA Statement: Wrong Time for Congress to Experiment on the Federal Employees Health Benefits Program
PCMA: New Study: Mail-Service Pharmacies Likely To Improve Prescription Drug Adherence
PCMA: New GAO Study: Lack of Competition Helping Drive ‘Extraordinary’ Brand-Name Drug Price Increases
PCMA: Real Biogenerics Reform, Not Pharma Deal ‘Shell Games,’ Will Lower Drug Costs
PCMA: NCPA ‘Poll’ Contradicts J.D. Power and Associates Survey on Mail-Service Pharmacy
PCMA: New J.D. Power and Associates Study Finds Consumer Satisfaction with Pharmacy Options
PCMA: Improving Affordability Critical to Reforming Health Care
PCMA: New Study Highlights ‘Market-Based’ Reforms to Lower Part D Drug Prices
PCMA: Real Reform Requires a Level Playing Field
PCMA Written Testimony for the U.S. Senate Commerce Subcommittee on Consumer Protection, Product Safety, and Insurance Hearing: “Competition in the Health Care Marketplace”
PCMA on Biogenerics Legislation: A Bellwether for Broader Health Reform Prospects
PCMA Statement on the Administration’s Comments Regarding Financing Health Care Reform
PCMA: New National Generic Pharmaceutical Study Finds Savings of $734 Billion Over the Last Decade
PCMA Launches New Ad Campaign:‘Waiting Isn’t An Option’ for Biogenerics
PCMA Study: New Stimulus Law Will Dramatically Increase E-Prescribing Adoption Rate
PCMA: New Bipartisan Biogenerics Legislation the ‘Right Approach’ to Increase Competition, Lower Costs
PCMA on New AARP Study: Biogenerics Will Help Lower Specialty Drug Costs for Consumers
PCMA Appoints Kristin Bass Senior Vice President of Policy
PCMA on Final Economic Stimulus Bill: Important Step Forward to Modernize and Improve Health Care
PCMA: It’s Time for Comparative Effectiveness
PCMA: HIT Bill An Opportunity for Huge Success… or Failure
PCMA: New Commonwealth Fund Survey Shows Patients Are Skipping Care Due to Costs
PCMA: New Analysis Highlights the Need for Rapid Physician Adoption of E-Prescribing
PCMA: New CBO Analysis Confirms Independent Pharmacy 'Collective Bargaining' Legislation Increases Costs for Consumers and Payors
PCMA: HHS Conference on E-Prescribing Will Accelerate Physician Adoption
PCMA: New Medicare Law Igniting Physician Groups to Adopt E-Prescribing
PCMA President and CEO Mark Merritt Testifies Before House Oversight & Government Reform Committee on Medicare Part D
PCMA: Consumers, Businesses, Unions, and Medical Professionals: Time for Congress to Act on E-Prescribing Legislation
PCMA: 'Protect Your Pharmacy Week' Should Focus on Safeguarding Part D Anti-Fraud Tools
PCMA: Employers - Proven PBM Tools Slowing Cost of Prescription Drug Benefits
PCMA: 2008 Health Debate Highlights 'Workable Solutions' Like E-Prescribing
Prime Therapeutics Joins PCMA
PCMA: CMS Releases Proposed E-Prescribing Standards in Medicare
PCMA on Electronic Health Records: The First Step is to Require E-Prescribing in Medicare
PCMA Statement on Independent Pharmacy Antitrust Legislation
PCMA Statement on New Average Manufacturer Price (AMP) Legislation
PCMA Statement on the Independent Drugstore Lobby Agenda
PCMA: Lessons of Katrina Highlight the Need for E-Prescribing in Medicare
PCMA Statement on Part D Survey Published in Health Affairs
PCMA: Minnesota is First in the Nation to Require E-Prescribing
PCMA: Part D Plans Continuing to Provide Robust Savings and Access for Beneficiaries
PCMA Statement Supporting New Average Manufacturer Price (AMP) Legislation
PCMA Statement on The Pharmacy Access Improvement (PhAIm) Act
New IMS Health Report Finds Generic Drugs Used More in Part D than Commercial Market
PCMA: New Report on Prescription Medication Adherence Underscores Importance of E-Prescribing
PCMA: E-Prescribing Could Prevent 1.9 Million Medication Errors, Save $26 Billion
PCMA: New E-Prescribing Initiative a 'Win-Win' For Patients and Physicians
PCMA Statement on Average Manufacturer Price (AMP) Rule in Medicaid
Aetna is PCMA's Newest Member
PCMA: PBMs Paying Clean Claims Within 30-Day Timeframe
PCMA: Beneficiaries in Part D Enjoying Savings and Broad Access on their Prescription Drugs
PCMA: New Study Finds Consumers Have Broad Access to Pharmacy Choices in Urban, Suburban, and Rural Areas
PCMA: New J.D. Power and Associates Study Finds High Consumer Satisfaction with Pharmacy Options
PCMA: National, Uniform Electronic-Prescribing Standard Needed to Increase Physician Adoption
PCMA: PBMs Projected to Save Medicare, Commercial Market $1.3 Trillion on Prescription Drug Costs From 2008-2017
PCMA Welcomes US Script as Newest Member
PCMA Welcomes Scriptrax as Newest Member
PCMA Releases 2007 Policy Agenda
PCMA: PBMs Negotiating Lower Drug Prices in Medicare Part D
PCMA Endorses Legislation to Create a Clear Regulatory Pathway for Biogenerics
PCMA: Seniors Flocking to Lower-Cost Generic Drugs in Medicare Part D
PCMA Supports National Discussion to Promote Value-based Purchasing in Health Care
PCMA: Part D Plans Projected to Save Seniors, Medicare Program $469 Billion over Ten Years
PCMA: Medicare Part B Program Could Save $14 Billion in Prescription Drug Costs through Biogenerics
PCMA: New Survey Showing One in Ten Physicians Use Electronic Prescribing Highlights Need for a National, Uniform Standard
Professional Affiliations
Former Vice President - Strategic Communications
Pharmaceutical Care Management Association (PCMA)
Biographic Information
Biographical information is available with Client Login.
About Us
|
Purchase Pro
|
Contact Us
© 2006-2010 Healthcare BizDev, Inc. All rights reserved.
Privacy Policy
|
Legal Conditions